Vladislav Sandler

At-a-Glance

Co-founder and CEO of Hemogenyx Pharmaceuticals Plc, a clinical-stage biopharmaceutical company
Co-founded Hemogenyx Pharmaceuticals Plc
Developing new medicines and treatments for blood and autoimmune diseases
Holds a PhD from the University of British Columbia
Instructor in Genetic Medicine at Weill Cornell Medicine

Biography

Vladislav Sandler is the co-founder and CEO of Hemogenyx Pharmaceuticals Plc, a clinical-stage biopharmaceutical company. The company focuses on developing new medicines and treatments for blood and autoimmune diseases, including leukemia, lymphoma, multiple sclerosis, and lupus. Hemogenyx Pharmaceuticals is developing distinct product candidates and a platform technology, operating a research facility in New York City.